Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-12-17

Clinical Trial Update: Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer [NA]

View source ↗

Summary

A trial update exploring whether adding oral zinc supplementation to chemotherapy modulates immune response in colon cancer patients undergoing adjuvant therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZINC (Zinc chloride)

Snippet

Sponsor: University of Sao Paulo | Conditions: Adjuvant Chemotherapy, Colon Cancer | NA | Status: UNKNOWN